ALB and liver dysplastic nodule: In this study, given the promising results of MR analysis in screening novel drug targets, we performed MR analysis between differentially expressed mitochondrial proteins and DN risk factors (eGFR, urinary albumin excretion and serum creatinine level), to screen potential therapeutic targets for DN.